Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference14 articles.
1. Trétarre B, Molinié F, Woronoff AS, Bossard N, Bessaoud F, Marrer E, et al. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012. Gynecol Oncol. 2015;139(2):324–9.
https://doi.org/10.1016/j.ygyno.2015.09.013
.
2. Coussy F, Chéreau E, Daraï E, Dhombres F, Lotz JP, Rouzier R, et al. Interest of CA 125 level in management of ovarian cancer. Gynecol Obstet Fertil. 2011;39(5):296–301.
https://doi.org/10.1016/j.gyobfe.2010.10.018.22
.
3. Paul P, Talukder S, Sangma MA, Saha PL, Begum M, Razi AZ, et al. Detection of ovarian tumor by color Doppler ultrasonography and CA-125. Mymensingh Med J. 2017;26(4):705–9. PubMed PMID: 29208855.
4. Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, López-Basave HN, Gómora MJ, Carlón E, et al. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. J Ovarian Res. 2016;9:41. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936203/
.
5. Varras M. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol. 2004;31(2):85–98. Review. PubMed PMID: 15266758.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献